Home LiteratureArticle Details
PMID: 3085299 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.

Transplantation ·Vol. 41 ·No. 5 ·1986-05-00 ·Pages 634-9

Cobbold S, Waldmann H

Abstract

The L3/T4+ and Lyt-2+ T-cell subsets can be depleted from mice, using selected monoclonal antibodies in vivo, at different times during rejection of, or priming to, allogeneic skin grafts. Although L3/T4+ cells are sufficient to reject skin grafts in naive Lyt-2-depleted mice, we show that Lyt-2+ cells can become involved, after an initial delay, in intact mice. Furthermore, these Lyt-2+ cells are primed to dominate the accelerated rejection of a normal secondary response. Mice depleted of L3/T4+ cells cannot be primed in this way, suggesting that priming of Lyt-2+ cells is dependent on help from L3/T4+ cells. However, in mice depleted of Lyt-2+ cells, priming for rapid rejection can be achieved, presumably via the L3/T4+ population. This suggests that the rejection of skin allografts in a given situation reflects different contributions of multiple effector mechanisms.

MeSH Terms
Animals Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte Antigens, Ly/immunology Antigens, Surface/analysis Graft Rejection Mice Mice, Inbred Strains Minor Histocompatibility Loci Rats Skin Transplantation T-Lymphocytes/classification,immunology Thymectomy
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte Antigens, Ly Antigens, Surface
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cobbold S
Waldmann H
Article Info
Journal
Transplantation
Abbr.
Transplantation
ISSN
0041-1337
Published
1986-05-00
Pages
634-9
Language
English
Region
United States
NLM ID
0132144
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com